Bath & Body Works, Inc. (NYSE:BBWI) Receives $42.06 Consensus Price Target from Brokerages

Key Points

• Bath & Body Works, Inc. has received a consensus recommendation of "Moderate Buy" from eighteen research firms, with fourteen analysts issuing buy ratings and an average twelve-month target price of $42.06.
• Large institutional investors have significantly increased their holdings, with Victory Capital Management growing its position by 14,732% in the first quarter, leading to 95.14% institutional ownership of the stock.
• The company recently announced a quarterly dividend of $0.20, with an annualized yield of 2.6% and a payout ratio of 21.33%.

Shares of Bath & Body Works, Inc. (NYSE:BBWI - Get Free Report) have received a consensus rating of "Moderate Buy" from the seventeen ratings firms that are currently covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and fourteen have issued a buy recommendation on the company. The average 1 year price target among brokerages that have covered the stock in the last year is $42.5333.

Several research analysts have commented on the company. JPMorgan Chase & Co. lifted their target price on Bath & Body Works from $40.00 to $46.00 and gave the stock an "overweight" rating in a report on Monday, July 28th. Piper Sandler set a $39.00 target price on Bath & Body Works and gave the company an "overweight" rating in a report on Thursday, May 15th. UBS Group increased their target price on Bath & Body Works from $32.00 to $36.00 and gave the stock a "neutral" rating in a research report on Tuesday, May 20th. Wall Street Zen downgraded Bath & Body Works from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Finally, Telsey Advisory Group reaffirmed an "outperform" rating and set a $38.00 price objective on shares of Bath & Body Works in a research note on Thursday.

Hedge Funds Weigh In On Bath & Body Works

Large investors have recently made changes to their positions in the business. Stonehage Fleming Financial Services Holdings Ltd purchased a new position in shares of Bath & Body Works during the second quarter valued at approximately $33,000. SVB Wealth LLC purchased a new position in shares of Bath & Body Works during the first quarter valued at approximately $35,000. Geneos Wealth Management Inc. lifted its holdings in shares of Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company's stock valued at $35,000 after purchasing an additional 801 shares during the last quarter. Parallel Advisors LLC raised its holdings in Bath & Body Works by 63.3% in the 2nd quarter. Parallel Advisors LLC now owns 1,241 shares of the company's stock worth $37,000 after acquiring an additional 481 shares during the last quarter. Finally, Golden State Wealth Management LLC raised its holdings in Bath & Body Works by 94.7% in the 1st quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock worth $40,000 after acquiring an additional 642 shares during the last quarter. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Bath & Body Works Price Performance

Bath & Body Works stock traded down $2.08 during mid-day trading on Tuesday, reaching $29.47. 17,266,529 shares of the company were exchanged, compared to its average volume of 5,192,907. The company has a fifty day simple moving average of $30.58 and a 200-day simple moving average of $30.90. Bath & Body Works has a 12 month low of $24.94 and a 12 month high of $41.87. The firm has a market cap of $6.24 billion, a PE ratio of 7.86, a PEG ratio of 1.05 and a beta of 1.54.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings data on Thursday, August 28th. The company reported $0.37 EPS for the quarter, hitting analysts' consensus estimates of $0.37. Bath & Body Works had a negative return on equity of 47.44% and a net margin of 11.10%.The firm had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.55 billion. During the same quarter last year, the company earned $0.37 EPS. The company's revenue was down .8% on a year-over-year basis. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. Sell-side analysts anticipate that Bath & Body Works will post 3.3 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 5th. Shareholders of record on Friday, August 22nd will be issued a $0.20 dividend. The ex-dividend date is Friday, August 22nd. This represents a $0.80 annualized dividend and a yield of 2.7%. Bath & Body Works's dividend payout ratio (DPR) is 21.33%.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.